(Q70664195)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7195642%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7195642%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

H Fodstad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7195642%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

I M Nilsson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7195642%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 January 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7195642%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7195642%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7195642%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7195642%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

25-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7195642%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01400969

13 October 2019

exact match

0 references

cites work

Coagulation and fibrinolytic activity of cerebrospinal fluid

1 reference

12 December 2020

Split products of fibrinogen after prolonged interaction with plasmin

1 reference

12 December 2020

Biochemical changes after spontaneous subarachnoid haemorrhage. 3. Coagulation and lysis with special reference to recurrent haemorrhage

1 reference

12 December 2020

Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action

1 reference

12 December 2020

Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin

1 reference

12 December 2020

Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans

1 reference

12 December 2020

Effect of fibrin degradation products on microvascular permeability

1 reference

12 December 2020

[Subarachnoid hemorrhages associated with increased fibrinolysis]

1 reference

12 December 2020

[Studies on the fibrinolytic system in ruptured intracranial aneurysm.--Part 2: Fibrinogen changes in acute stage of SAH as a risk factor of the ischemic complications following vasospasm (author's transl)]

1 reference

12 December 2020

Trends in microvascular research. The microembolism syndrome

1 reference

12 December 2020

Local fibrinolysis in cerebral and subarachnoid hemorrhage

1 reference

12 December 2020

Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage.

1 reference

12 December 2020

Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study.

1 reference

12 December 2020

Antifibrinolytic Therapy in Ruptured Intracranial Aneurysm Through Repeated Monitoring of Fibrinolytic Activity of Blood

1 reference

12 December 2020

Fibrin-fibrinogen degradation products in cerebrospinal fluid

1 reference

12 December 2020

The biological and pharmacological properties of some fibrinogen degradation products.

1 reference

12 December 2020

Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?

1 reference

12 December 2020

Fibrinolytic activity of cerebro-spinal fluid and the development of artificial cerebral haematomas in dogs

1 reference

12 December 2020

Fibrinolysis in subarachnoid haemorrhage

1 reference

12 December 2020

Treatment of subarachnoid hemorrhage: the ability of epsilon aminocaproic acid to cross the blood brain barrier and reduce the spinal fluid fibrinolytic activity

1 reference

12 December 2020

Fibrin/fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit

1 reference

12 December 2020

Separation and estimation split "products" of fibrinogen and fibrin in human serum

1 reference

12 December 2020

Plasminogen depletion during administration of epsilon-aminocarproic acid

1 reference

12 December 2020

Coagulation Abnormalities in Subarachnoid Hemorrhage

1 reference

12 December 2020

The alpha2-macroglobulin level in cerebrospinal fluid; a parameter for the condition of the blood-CSF barrier.

1 reference

12 December 2020

Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA

1 reference

12 December 2020

Subarachnoid haemorrhage. Time sequence of recurrences and their prognosis

1 reference

12 December 2020

Streptokinase clot lysis time in patients with ruptured intracranial aneurysms

1 reference

12 December 2020

On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time.

1 reference

12 December 2020

Clinical Experiences with ε‐Aminocaproic Acid (ε‐ACA) as an Antifibrinolytic Agent

1 reference

12 December 2020

Differentiation between plasminogen activators by means of epsilon-aminocaproic acid

1 reference

12 December 2020

Determination of alpha-2-macroglobulin as trypsin-protein esterase

1 reference

12 December 2020

Fibrinolytic activity in experimental subarachnoid bleeding in dogs.

1 reference

12 December 2020

Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?

1 reference

12 December 2020

Significance of vasospasm in the treatment of ruptured intracranial aneurysms

1 reference

12 December 2020

Fibrin degradation products in the serum and cerebrospinal fluid of patients with group A meningococcal meningitis

1 reference

12 December 2020

Incidence, aetiology, and prognosis of primary subarachnoid haemorrhage. A study based on 589 cases diagnosed in a defined urban population during a defined period

1 reference

12 December 2020

Haemophilia in Sweden. I. Coagulation studies

1 reference

12 December 2020

Fibrinolytic activity of cerebrospinal fluid in subarachnoid hemorrhage (author's transl)

1 reference

12 December 2020

Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations

1 reference

12 December 2020

[Studies on the fibrinolytic activity of the cerebrospinal fluid and the effect of PAMBA]

1 reference

12 December 2020

Fibrinolytic activity of the spinal fluid and meninges

1 reference

12 December 2020

Hypothermia, and interruption of carotid, or carotid and vertebral circulation, in the surgical management of intracranial aneurysms.

1 reference

12 December 2020

Determination of fibrinogen and fibrinogenolytic activity

1 reference

12 December 2020

[Effect of products of plasma degradation of fibrinogen on the permeability of capillaries]

1 reference

12 December 2020

The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage

1 reference

12 December 2020

Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke

1 reference

12 December 2020

Plasminogen in Normal and Abnormal Human Cerebrospinal Fluid

1 reference

12 December 2020

Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity

1 reference

12 December 2020

Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids

1 reference

12 December 2020

Increased fibrinolytic activity and fibrin degradation products after experimental intracerebral haemorrhage

1 reference

12 December 2020

Fibrinolytic Activity in Blood and Cerebrospinal Fluid in Subarachnoid Hemorrhage from Ruptured Intracranial Saccular Aneurysm before and during EACA Treatment

1 reference

12 December 2020

Isolation of vasoactive peptides from human fibrin and fibrinogen degraded by plasmin

1 reference

12 December 2020

Monitoring antifibrinolytic therapy in subarachnoid hemorrhage

1 reference

12 December 2020

Metabolism of plasminogen in healthy subjects: effect of tranexamic acid

1 reference

12 December 2020

Ruptured intracranial aneurysms. Case morbidity and mortality

1 reference

12 December 2020

Fibrinolytic activity in the walls of cerebral saccular aneurysms

1 reference

12 December 2020

Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01400969

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7195642%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference